selected publications
- Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial. JAMA network open. 2024 Academic Article GET IT
- Effect of Montelukast vs Placebo on Time to Sustained Recovery in Outpatients with COVID-19: The ACTIV-6 Randomized Clinical Trial. 2024 GET IT
- Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial. JAMA network open. 2024 Academic Article GET IT
- Single Intravenous Dose Dalbavancin Pathway for the Treatment of Acute Bacterial Skin and Skin Structure Infections: Considerations for Emergency Department Implementation and Cost Savings. The Journal of emergency medicine. 2024 Academic Article GET IT
- Progress toward realizing the promise of decentralized clinical trials. Journal of clinical and translational science. 2024 Editorial Article GET IT
- Intravenous immunoglobulin as a potential treatment for long COVID. Expert opinion on biological therapy. 2023 Academic Article GET IT
- Infliximab Concentrations in Participants with Moderate to Severe COVID-19. Journal of clinical pharmacology. 2023 Letter GET IT
- The ACTIV-6 Stakeholder Advisory Committee: a model for virtual engagement in decentralized clinical trials. Journal of clinical and translational science. 2023 Academic Article GET IT
- Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19. The New England journal of medicine. 2023 Academic Article GET IT
- Paxlovid as a potential treatment for long COVID. Expert opinion on pharmacotherapy. 2023 Academic Article GET IT
-
Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
JAMA.
2023
Academic Article
GET IT
Times cited: 32 - Optimizing the use of vilobelimab for the treatment of COVID-19. Expert opinion on biological therapy. 2023 Academic Article GET IT
- Metformin as a potential treatment for COVID-19. Expert opinion on pharmacotherapy. 2023 Review GET IT
- Fluvoxamine vs Placebo and Time to Recovery in Outpatients With Mild to Moderate COVID-19-Reply. JAMA. 2023 Comment GET IT
- Interferon lambda as a potential treatment for COVID-19. Expert opinion on biological therapy. 2023 Academic Article GET IT
-
Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.
JAMA.
2023
Academic Article
GET IT
Times cited: 37 - VV116 as a potential treatment for COVID-19. Expert opinion on pharmacotherapy. 2023 Academic Article GET IT
- Anakinra as a potential treatment for COVID-19. Drugs of today (Barcelona, Spain : 1998). 2023 Academic Article GET IT
- Meeting the Challenges of Sepsis in Severe Coronavirus Disease 2019: A Call to Arms. Open forum infectious diseases. 2022 Academic Article GET IT
- Osteoarticular Mycoses. Clinical microbiology reviews. 2022 Review GET IT
- Infliximab as a potential treatment for COVID-19. Expert review of anti-infective therapy. 2022 Academic Article GET IT
- Ensitrelvir as a potential treatment for COVID-19. Expert opinion on pharmacotherapy. 2022 Academic Article GET IT
- Optimizing the use of Paxlovid in clinical practice. Drugs of today (Barcelona, Spain : 1998). 2022 Academic Article GET IT
- Treatment of severe COVID-19: an evolving paradigm. Expert opinion on pharmacotherapy. 2022 Academic Article GET IT
- Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial. JAMA. 2022 Academic Article GET IT
- Original antigen sin and COVID-19: implications for seasonal vaccination. Expert opinion on biological therapy. 2022 Academic Article GET IT
- Novel Strategies for the Treatment of COVID-19. Drugs in R&D. 2022 Academic Article GET IT
- Fluticasone propionate as a potential treatment for COVID-19. Drugs of today (Barcelona, Spain : 1998). 2022 Academic Article GET IT
- Exebacase: A Novel Approach to the Treatment of Staphylococcal Infections. Drugs in R&D. 2022 Review GET IT
- Current and emerging immunomodulators for treatment of SARS-CoV2 infection (COVID-19). Expert opinion on pharmacotherapy. 2022 Academic Article GET IT
-
The Diagnostic Accuracy Of Procalcitonin for Urinary Tract Infection in Hospitalized Older Adults: a Prospective Study.
Journal of general internal medicine.
2022
Academic Article
GET IT
Times cited: 8 - Pharmacokinetics and Pharmacodynamics of Ibrexafungerp. Drugs in R&D. 2021 Review GET IT
- Ethical challenges of prospective clinical trials during the COVID-19 pandemic. Expert review of anti-infective therapy. 2021 Academic Article GET IT
- The Great Gatsby and the challenge of unreliable narrators. Lancet (London, England). 2021 Academic Article GET IT
- Clinical Pharmacokinetics and Pharmacodynamics of Lefamulin. Clinical pharmacokinetics. 2021 Information Resource GET IT
-
At-home coronavirus testing: the next game-changer?.
Expert review of molecular diagnostics.
2021
Editorial Article
GET IT
Times cited: 1 - Efficacy of Amphotericin B in Corneal Preservation Media After Extended Frozen Storage. Cornea. 2020 Academic Article GET IT
-
Harnessing the potential of CRISPR-based platforms to advance the field of hospital medicine.
Expert review of anti-infective therapy.
2020
Information Resource
GET IT
Times cited: 9 -
Clinical Pharmacokinetics and Pharmacodynamics of Imipenem-Cilastatin/Relebactam Combination Therapy.
Clinical pharmacokinetics.
2020
Information Resource
GET IT
Times cited: 4 -
Cefiderocol to treat complicated urinary tract infection.
Drugs of today (Barcelona, Spain : 1998).
2020
Information Resource
GET IT
Times cited: 3 -
Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial.
Infectious diseases and therapy.
2019
Academic Article
GET IT
Times cited: 30 - Procalcitonin utilization in the real world: An observational study of antibiotic prescribing practices. Journal of evaluation in clinical practice. 2019 Academic Article GET IT
-
Clinical Pharmacokinetics and Pharmacodynamics of Eravacycline.
Clinical pharmacokinetics.
2019
Information Resource
GET IT
Times cited: 6 -
Clinical Progress Note: Procalcitonin in the Diagnosis and Management of Community-Acquired Pneumonia in Hospitalized Adults.
Journal of hospital medicine.
2019
Academic Article
GET IT
Times cited: 1 -
Frequency of Ethical Issues on a Hospitalist Teaching Service at an Urban, Tertiary Care Center.
Journal of hospital medicine.
2019
Academic Article
GET IT
Times cited: 5 -
The expanding use of matrix-assisted laser desorption/ionization-time of flight mass spectroscopy in the diagnosis of patients with mycotic diseases.
Expert review of molecular diagnostics.
2019
Information Resource
GET IT
Times cited: 9 - Challenges of developing new drugs to treat MRSA. Drugs of the Future. 2019 Article GET IT
-
Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole.
Clinical pharmacokinetics.
2018
Information Resource
GET IT
Times cited: 13 -
Teixobactin: a novel anti-infective agent.
Expert review of anti-infective therapy.
2018
Editorial Article
GET IT
Times cited: 12 - The surviving sepsis controversy: a call to action for hospital medicine. Expert review of anti-infective therapy. 2018 Academic Article GET IT
-
Candidemia in the cancer patient: diagnosis, treatment, and future directions.
Expert review of anti-infective therapy.
2018
Information Resource
GET IT
Times cited: 9 -
Recent Advances in the Treatment of Scedosporiosis and Fusariosis.
Journal of fungi (Basel, Switzerland).
2018
Information Resource
GET IT
Times cited: 60 -
The rise of hospitalists: an opportunity for infectious diseases investigators.
Expert review of anti-infective therapy.
2018
Academic Article
GET IT
Times cited: 3 -
Amino Acid Metabolism and Transport Mechanisms as Potential Antifungal Targets.
International journal of molecular sciences.
2018
Information Resource
GET IT
Times cited: 30 -
Cefiderocol: a novel siderophore cephalosporin.
Expert opinion on investigational drugs.
2018
Information Resource
GET IT
Times cited: 31 - The prognostic value of mid-regional pro-adrenomedullin in the evaluation of acute dyspnea. Expert review of molecular diagnostics. 2018 Information Resource GET IT
-
Off the Charts: Medical documentation and selective redaction in the age of transparency.
Perspectives in biology and medicine.
2018
Academic Article
GET IT
Times cited: 2 -
Novel applications for serum procalcitonin testing in clinical practice.
Expert review of molecular diagnostics.
2017
Information Resource
GET IT
Times cited: 22 -
Containment strategies to address the expanding threat of multidrug-resistant Candida auris.
Expert review of anti-infective therapy.
2017
Information Resource
GET IT
Times cited: 3 -
In vitro combination therapy with isavuconazole against Candida spp.
Medical mycology.
2017
Academic Article
GET IT
Times cited: 8 -
Meropenem/vaborbactam fixed combination for the treatment of patients with complicated urinary tract infections.
Drugs of today (Barcelona, Spain : 1998).
2017
Information Resource
GET IT
Times cited: 4 -
Fungal Infections of the Central Nervous System in Children.
Journal of the Pediatric Infectious Diseases Society.
2017
Information Resource
GET IT
Times cited: 14 -
Combination Therapy with Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis.
Antimicrobial agents and chemotherapy.
2017
Academic Article
GET IT
Times cited: 14 -
Future Research Priorities in Fungal Resistance.
The Journal of infectious diseases.
2017
Academic Article
GET IT
Times cited: 20 -
Drugs currently under investigation for the treatment of invasive candidiasis.
Expert opinion on investigational drugs.
2017
Information Resource
GET IT
Times cited: 14 -
Special considerations for the diagnosis and treatment of invasive pulmonary aspergillosis.
Expert review of respiratory medicine.
2017
Information Resource
GET IT
Times cited: 2 -
Translational Development and Application of (1→3)-β-d-Glucan for Diagnosis and Therapeutic Monitoring of Invasive Mycoses.
International journal of molecular sciences.
2017
Information Resource
GET IT
Times cited: 20 -
Drug development challenges and strategies to address emerging and resistant fungal pathogens.
Expert review of anti-infective therapy.
2017
Information Resource
GET IT
Times cited: 24 -
Combination therapy for the treatment of pulmonary mold infections.
Expert review of respiratory medicine.
2017
Information Resource
GET IT
Times cited: 4 -
Nucleic acid amplification methodologies for the detection of pulmonary mold infections.
Expert review of molecular diagnostics.
2017
Information Resource
GET IT
Times cited: 7 -
Prophylactic Measures During Induction for Acute Myeloid Leukemia.
Current oncology reports.
2017
Information Resource
GET IT
Times cited: 10 -
Diagnosis, classification, and therapeutic interventions for sinopulmonary Aspergillosis.
Expert review of respiratory medicine.
2017
Information Resource
GET IT
Times cited: 5 -
The Rise of Hospitalists: An Opportunity for Clinical Ethics.
The Journal of clinical ethics.
2017
Academic Article
GET IT
Times cited: 3 - The fungal meningitis outbreak five years later: What have we learned about Exserohilum rostratum?. Expert Review of Precision Medicine and Drug Development. 2017 Article GET IT
-
Molecular diagnosis of invasive mycoses of the central nervous system.
Expert review of molecular diagnostics.
2016
Information Resource
GET IT
Times cited: 10 -
PCR methodology and applications for the detection of human fungal pathogens.
Expert review of molecular diagnostics.
2016
Information Resource
GET IT
Times cited: 22 -
Transgender Patients, Hospitalists, and Ethical Care.
Perspectives in biology and medicine.
2016
Academic Article
GET IT
Times cited: 5 -
What Hospitalists Should Know About Intersex Adults.
Perspectives in biology and medicine.
2016
Academic Article
GET IT
Times cited: 1 -
Emerging drugs and vaccines for candidemia.
Mycoses.
2014
Information Resource
GET IT
Times cited: 32 -
Use of a commercial HIV co-receptor tropism assay in clinical practice.
AIDS patient care and STDs.
2014
Article
GET IT
Times cited: 1 -
In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.
The Journal of antimicrobial chemotherapy.
2014
Academic Article
GET IT
Times cited: 97 -
In vitro combination of isavuconazole with micafungin or amphotericin B deoxycholate against medically important molds.
Antimicrobial agents and chemotherapy.
2014
Academic Article
GET IT
Times cited: 40 -
Mold infections of the central nervous system.
The New England journal of medicine.
2014
Information Resource
GET IT
Times cited: 149